Literature DB >> 26323992

Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).

Jan Bauer1, Ralf Gold2, Ortwin Adams3, Hans Lassmann4.   

Abstract

Progressive multifocal leukoencephalopathy is a viral encephalitis induced by the John Cunningham (JC) virus, an ubiquitous neurotropic papovavirus of the genus polyomavirus that in healthy people in latency resides in kidney and bone marrow cells. Activation and entry into the CNS were first seen in patients with malignancies of the hematopoietic system and an impaired immune system. During the 1980 and the 1990s with the appearance of human immunodeficiency virus infection in humans, PML was found to be the most important opportunistic infection of the central nervous system. As a result of highly efficient immunosuppressive and immunomodulatory treatments, in recent years, the number of PML cases again increased. PML is prevented by an intact cellular immune response and accordingly immune reconstitution can terminate established disease in the CNS. However, forced immune reconstitution can lead to massive destruction of virus-infected cells. This may result in clinical exacerbation associated with high morbidity and mortality and referred to as PML with immune reconstitution inflammatory syndrome (PML-IRIS). In the present review, we discuss virological properties and routes of infection in the CNS, but mostly focus on the pathology of PML and PML-IRIS and on the role of the immune system in these disorders. We show that PML and PML-IRIS result from predominant JC virus infection of oligodendrocytes and, to a lesser extent, of infected neurons. Inflammation in these encephalitides seems to be driven by a dominant cytotoxic T cell response which is massively exaggerated during IRIS.

Entities:  

Keywords:  Immune reconstitution inflammatory syndrome; JC virus; Neuropathology; Progressive multifocal leukoencephalopathy; T cell cytotoxicity

Mesh:

Year:  2015        PMID: 26323992     DOI: 10.1007/s00401-015-1471-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.

Authors:  Jessie Grewal; Poorvi Dalal; Michelle Bowman; Behiye Kaya; José Javier Otero; Jaime Imitola
Journal:  J Neurovirol       Date:  2016-06-06       Impact factor: 2.643

Review 2.  Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.

Authors:  Emanuele D'Amico; Aurora Zanghì; Carmela Leone; Hayrettin Tumani; Francesco Patti
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

Review 3.  The neuropathology of the adult cerebellum.

Authors:  Arnulf H Koeppen
Journal:  Handb Clin Neurol       Date:  2018

4.  Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.

Authors:  Aabha Oza; Michael P Rettig; Phil Powell; Kathryn O'Brien; David B Clifford; Julie Ritchey; Leah Gehrs; Julia Hollaway; Eugene Major; Todd A Fehniger; Christopher A Miller; Patrick Soon-Shiong; Amy Rock; John F DiPersio
Journal:  Blood Adv       Date:  2020-06-09

5.  HIV-associated PML may appear inflammatory because of higher CD4 count.

Authors:  Joy Zhuo Ding; Ryan Gotfrit; Carlos Torres
Journal:  Neurol Clin Pract       Date:  2019-12

6.  Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Authors:  Eileen M Geoghegan; Diana V Pastrana; Rachel M Schowalter; Upasana Ray; Wei Gao; Mitchell Ho; Gary T Pauly; Dina M Sigano; Campbell Kaynor; Ellen Cahir-McFarland; Benoit Combaluzier; Jan Grimm; Christopher B Buck
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

Review 7.  Multiple Sclerosis Pathology.

Authors:  Hans Lassmann
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

8.  Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.

Authors:  Susanne Laukoter; Helmut Rauschka; Anna R Tröscher; Ulrike Köck; Etsuji Saji; Kurt Jellinger; Hans Lassmann; Jan Bauer
Journal:  Acta Neuropathol       Date:  2016-11-05       Impact factor: 17.088

9.  PET Imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in Progressive Multifocal Leukoencephalopathy.

Authors:  Kenji Ishibashi; Yoshiharu Miura; Ken Matsumura; Yusuke Kanemasa; Kazuo Nakamichi; Masayuki Saijo; Jun Toyohara; Kenji Ishii
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

Review 10.  Neurological safety of fingolimod: An updated review.

Authors:  Fumihito Yoshii; Yusuke Moriya; Tomohide Ohnuki; Masafuchi Ryo; Wakoh Takahashi
Journal:  Clin Exp Neuroimmunol       Date:  2017-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.